Jazz Pharmaceuticals (JAZZ) Finished Goods (2010 - 2019)

Jazz Pharmaceuticals' Finished Goods history runs 10 years deep, the most recent figure standing at $22.3 million for Q1 2019.

• In Q1 2019, Finished Goods changed N/A year-over-year to $22.3 million; the TTM figure through Mar 2019 stood at $22.3 million (changed N/A YoY), while the FY2018 annual figure was $21.3 million, down 11.22% from the prior year.
• Finished Goods for Q1 2019 stood at $22.3 million, up from $21.3 million in the prior quarter.
• The five-year high for Finished Goods was $24.0 million in Q4 2017, with the low at $5.0 million in Q4 2015.
• The 5-year median for Finished Goods is $17.9 million (2018), against an average of $16.0 million.
• The sharpest annual moves came in 2015 and 2016: Finished Goods sank 69.83% in 2015, then surged 175.91% in 2016.
• Jazz Pharmaceuticals' Finished Goods stood at $5.0 million in 2015, then soared by 175.91% to $13.8 million in 2016, then jumped by 73.8% to $24.0 million in 2017, then slipped by 11.22% to $21.3 million in 2018, then increased by 4.68% to $22.3 million in 2019.
• Business Quant data shows JAZZ's Finished Goods at $22.3 million in Q1 2019, $21.3 million in Q4 2018, and $17.9 million in Q2 2018.